GlassScriptPhysician profile
Devon J O'Guinn
NPI 1215381116
$2,108.93
in general payments reported to CMS, 2019-2025
11 companies · $442 in 2025
The $442 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $180 · 2023: $178 · 2024: $1,309 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,929.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $576.90 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $443.42 | 2022-2025 | Kyphon Express II Kyphopak Tray |
| Penumbra, INC. | $381.10 | 2024 | Indigo System, Penumbra System |
| Balt USA, LLC | $213.66 | 2024 | Prestige Coil System |
| Sirtex Medical INC | $158.78 | 2024 | Sir-Spheres Microspheres |
| Angiodynamics, INC. | $121.08 | 2023 | Auryon Laser System 100-120 Vac |
| Philips North America LLC | $71.44 | 2025 | IV Other |
| Trisalus Life Sciences, INC. | $53.93 | 2024 | Trinav Infusion System |
| Terumo Medical Corporation | $45.95 | 2023 | Azur Cx Detachable |
| Cardiovascular Systems INC. | $26.22 | 2022-2023 | Diamondback Peripheral |
| Bard Peripheral Vascular, INC. | $16.45 | 2024 | Trek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devon O'Guinn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.